- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.K. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
1 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
GSK
Market Cap: UK£71.7b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
New
GSK
UK£17.84
7D
0.9%
1Y
37.1%
AstraZeneca
Market Cap: UK£209.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£135.32
7D
4.9%
1Y
35.6%